NCT03468387 (PREvsSPC) is a NA clinical trial of Primary realignment in Urethral Injury, sponsored by Assiut University.

Who is sponsoring NCT03468387?

NCT03468387 is sponsored by Assiut University.

What drugs are being tested in NCT03468387?

Interventions in NCT03468387: Primary realignment, Suprapubic cystostomy.

What condition does NCT03468387 study?

NCT03468387 studies Urethral Injury.

Is NCT03468387 still recruiting?

NCT03468387 is currently status unknown. Last updated 1 May 2018.

Last reviewed 2018-05-01 · How we verify

NCT03468387: PREvsSPC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Primary Urethral Realignment vs. Suprapubic Cystostomy for Initial Management of Pediatric Pelvic Fracture Urethral Injury

Status unknown NA Last updated 1 May 2018

What this trial tests

NA trial testing Primary realignment in Urethral Injury in 42 participants. Status unknown.

Timeline

1 June 2018

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	42
Start date	1 June 2018
Primary completion	1 June 2021
Estimated completion	1 June 2021

Drugs / interventions tested

Primary realignment
Suprapubic cystostomy

Conditions studied

Urethral Injury — all drugs for Urethral Injury →

Sponsor

Assiut University

Who can join

Adults 1 to 18, male only, with Urethral Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is prospective randomized comparative clinical trial comparing primary urethral realignment vs. suprapubic cystostomy in initial management of pediatric pelvic fracture urethral injury regarding: 1. The success rate after initial intervention. 2. The need for urethroplasty in the failed realignment group and cystostomy group. 3. The success rate of urethroplasty in the failed realignment group and cystostomy group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03468387 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 1 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03468387.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing